# Filing Detail

Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-25-021251
Filing Date
2025-03-06
Accepted
2025-03-06 17:17:56
Documents
101

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | ea0233170-posam1_oruka.htm iXBRL | POS AM | 1942676
2 | OPINION OF GIBSON, DUNN & CRUTCHER LLP | ea023317001ex5-1_oruka.htm | EX-5.1 | 8556
3 | CONSENT OF PRICEWATERHOUSECOOPERS LLP | ea023317001ex23-1_oruka.htm | EX-23.1 | 1473
4 | GRAPHIC | image_001.jpg | GRAPHIC | 5350
5 | GRAPHIC | image_002.jpg | GRAPHIC | 25823
6 | GRAPHIC | image_003.jpg | GRAPHIC | 38446
7 | GRAPHIC | image_004.jpg | GRAPHIC | 33760
8 | GRAPHIC | image_005.jpg | GRAPHIC | 6576
9 | GRAPHIC | image_006.jpg | GRAPHIC | 12771
10 | GRAPHIC | image_007.jpg | GRAPHIC | 26867
11 | GRAPHIC | image_008.jpg | GRAPHIC | 30353
12 | GRAPHIC | image_009.jpg | GRAPHIC | 25557
13 | GRAPHIC | ex5-1_001.jpg | GRAPHIC | 2675
| Complete submission text file | 0001213900-25-021251.txt |  | 8748841

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL SCHEMA FILE | orka-20241231.xsd | EX-101.SCH | 82884
15 | XBRL CALCULATION FILE | orka-20241231_cal.xml | EX-101.CAL | 45629
16 | XBRL DEFINITION FILE | orka-20241231_def.xml | EX-101.DEF | 393816
17 | XBRL LABEL FILE | orka-20241231_lab.xml | EX-101.LAB | 695412
18 | XBRL PRESENTATION FILE | orka-20241231_pre.xml | EX-101.PRE | 418344
103 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0233170-posam1_oruka_htm.xml | XML | 810170

Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-283212 | Film No.: 25716364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)